MedPath

Human Milk and Infant Intestinal Microbiome Study

Not Applicable
Completed
Conditions
Breast Feeding
Human Microbiome
Registration Number
NCT03181269
Lead Sponsor
University of Virginia
Brief Summary

This study will explore the effects of skin-to-skin contact (SSC) between mothers and their babies on the infant intestinal microbiome, the maternal skin microbiome and the breast milk microbiome. This will be accomplished by administering an intervention education session to one group and a placebo education session to the second group in order to influence the magnitude of total SSC defined by the frequency and duration of contact time between the two groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • Pregnant women scheduled to deliver at the University of Virginia Health System
  • Women 18 years or older and their newborn infant
  • Stated intent to exclusively breastfeed for the duration of post-partum hospital admission
  • To have physical custody of their child when they are discharged from the hospital
Exclusion Criteria
  • Maternal antibiotic use in the 3 months prior to delivery
  • Consumption of alcohol in the 3 months prior to delivery
  • Recreational drug use in the 3 months prior to delivery
  • Serious gastrointestinal conditions requiring medical intervention or medication during pregnancy (e.g. Crohn's disease, ulcerative colitis, celiac disease, gastrointestinal infections)
  • Serious health conditions that require medication during pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Skin-to-skin contactDuration of hospital admission after delivery (2-3 days)

Self-reported magnitude of maternal-infant skin-to-skin contact

Secondary Outcome Measures
NameTimeMethod
Maternal dietary intakeDuring pregnancy

Maternal dietary intake of probiotic or culture-enhanced foods

Maternal breast milk microbiomeDuration of hospital admission after delivery (2-3 days)

Maternal first and early milk microbiome

Infant intestinal microbiomeDuration of hospital admission after delivery (2-3 days)

Infant fecal microbiome

Maternal skin microbiomeDuration of hospital admission after delivery (2-3 days)

Maternal breast area skin microbiome

Trial Locations

Locations (1)

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

University of Virginia
🇺🇸Charlottesville, Virginia, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.